KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Merck (MRK) over the last 16 years, with Q3 2025 value amounting to $5.8 billion.

  • Merck's Net Income towards Common Stockholders rose 8307.5% to $5.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0 billion, marking a year-over-year increase of 5657.32%. This contributed to the annual value of $17.1 billion for FY2024, which is 444456.23% up from last year.
  • Per Merck's latest filing, its Net Income towards Common Stockholders stood at $5.8 billion for Q3 2025, which was up 8307.5% from $4.4 billion recorded in Q2 2025.
  • Merck's Net Income towards Common Stockholders' 5-year high stood at $5.8 billion during Q3 2025, with a 5-year trough of -$6.0 billion in Q2 2023.
  • For the 4-year period, Merck's Net Income towards Common Stockholders averaged around $2.4 billion, with its median value being $3.5 billion (2024).
  • As far as peak fluctuations go, Merck's Net Income towards Common Stockholders tumbled by 11185.47% in 2021, and later surged by 40538.34% in 2024.
  • Merck's Net Income towards Common Stockholders (Quarter) stood at -$62.0 million in 2021, then crashed by 1877.42% to -$1.2 billion in 2023, then skyrocketed by 405.38% to $3.7 billion in 2024, then soared by 54.57% to $5.8 billion in 2025.
  • Its Net Income towards Common Stockholders was $5.8 billion in Q3 2025, compared to $4.4 billion in Q2 2025 and $5.1 billion in Q1 2025.